Designer drugs on the Internet: A phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly

Ornella Corazza, Fabrizio Schifano, Magi Farre, Paolo Deluca, Zoe Davey, Colin Drummond, Marta Torrens, Z. Demetrovics, Lucia Di Furia, Liv Flesland, Barbara Mervó, Jacek Moskalewicz, Agnieszka Pisarska, Harry Shapiro, Holger Siemann, Arvid Skutle, Cinzia Pezzolesi, Peer van der Kreeft, Norbert Scherbaum

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon.

Original languageEnglish
Pages (from-to)125-129
Number of pages5
JournalCurrent Clinical Pharmacology
Volume6
Issue number2
DOIs
Publication statusPublished - May 2011

Fingerprint

Designer Drugs
Odonata
Hallucinogens
Diptera
Internet
Literature
Lysergic Acid Diethylamide
Psychotropic Drugs
Toxicology
Public Health
Pharmacology

Keywords

  • ABDF
  • Bromo-dragonfly
  • Designer drugs
  • FLY-compounds
  • Internet monitoring
  • Phenethylamines
  • ReDNet project
  • Research chemicals

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Designer drugs on the Internet : A phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly. / Corazza, Ornella; Schifano, Fabrizio; Farre, Magi; Deluca, Paolo; Davey, Zoe; Drummond, Colin; Torrens, Marta; Demetrovics, Z.; Di Furia, Lucia; Flesland, Liv; Mervó, Barbara; Moskalewicz, Jacek; Pisarska, Agnieszka; Shapiro, Harry; Siemann, Holger; Skutle, Arvid; Pezzolesi, Cinzia; van der Kreeft, Peer; Scherbaum, Norbert.

In: Current Clinical Pharmacology, Vol. 6, No. 2, 05.2011, p. 125-129.

Research output: Contribution to journalArticle

Corazza, O, Schifano, F, Farre, M, Deluca, P, Davey, Z, Drummond, C, Torrens, M, Demetrovics, Z, Di Furia, L, Flesland, L, Mervó, B, Moskalewicz, J, Pisarska, A, Shapiro, H, Siemann, H, Skutle, A, Pezzolesi, C, van der Kreeft, P & Scherbaum, N 2011, 'Designer drugs on the Internet: A phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly', Current Clinical Pharmacology, vol. 6, no. 2, pp. 125-129. https://doi.org/10.2174/157488411796151129
Corazza, Ornella ; Schifano, Fabrizio ; Farre, Magi ; Deluca, Paolo ; Davey, Zoe ; Drummond, Colin ; Torrens, Marta ; Demetrovics, Z. ; Di Furia, Lucia ; Flesland, Liv ; Mervó, Barbara ; Moskalewicz, Jacek ; Pisarska, Agnieszka ; Shapiro, Harry ; Siemann, Holger ; Skutle, Arvid ; Pezzolesi, Cinzia ; van der Kreeft, Peer ; Scherbaum, Norbert. / Designer drugs on the Internet : A phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly. In: Current Clinical Pharmacology. 2011 ; Vol. 6, No. 2. pp. 125-129.
@article{6a74f0629a46443b99feabd7185d66b4,
title = "Designer drugs on the Internet: A phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly",
abstract = "Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon.",
keywords = "ABDF, Bromo-dragonfly, Designer drugs, FLY-compounds, Internet monitoring, Phenethylamines, ReDNet project, Research chemicals",
author = "Ornella Corazza and Fabrizio Schifano and Magi Farre and Paolo Deluca and Zoe Davey and Colin Drummond and Marta Torrens and Z. Demetrovics and {Di Furia}, Lucia and Liv Flesland and Barbara Merv{\'o} and Jacek Moskalewicz and Agnieszka Pisarska and Harry Shapiro and Holger Siemann and Arvid Skutle and Cinzia Pezzolesi and {van der Kreeft}, Peer and Norbert Scherbaum",
year = "2011",
month = "5",
doi = "10.2174/157488411796151129",
language = "English",
volume = "6",
pages = "125--129",
journal = "Current Clinical Pharmacology",
issn = "1574-8847",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Designer drugs on the Internet

T2 - A phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly

AU - Corazza, Ornella

AU - Schifano, Fabrizio

AU - Farre, Magi

AU - Deluca, Paolo

AU - Davey, Zoe

AU - Drummond, Colin

AU - Torrens, Marta

AU - Demetrovics, Z.

AU - Di Furia, Lucia

AU - Flesland, Liv

AU - Mervó, Barbara

AU - Moskalewicz, Jacek

AU - Pisarska, Agnieszka

AU - Shapiro, Harry

AU - Siemann, Holger

AU - Skutle, Arvid

AU - Pezzolesi, Cinzia

AU - van der Kreeft, Peer

AU - Scherbaum, Norbert

PY - 2011/5

Y1 - 2011/5

N2 - Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon.

AB - Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon.

KW - ABDF

KW - Bromo-dragonfly

KW - Designer drugs

KW - FLY-compounds

KW - Internet monitoring

KW - Phenethylamines

KW - ReDNet project

KW - Research chemicals

UR - http://www.scopus.com/inward/record.url?scp=79959367083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959367083&partnerID=8YFLogxK

U2 - 10.2174/157488411796151129

DO - 10.2174/157488411796151129

M3 - Article

C2 - 21592070

AN - SCOPUS:79959367083

VL - 6

SP - 125

EP - 129

JO - Current Clinical Pharmacology

JF - Current Clinical Pharmacology

SN - 1574-8847

IS - 2

ER -